HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GTP analogues cause release of the alpha subunit of the GTP binding protein, GO, from the plasma membrane of NG108-15 cells.

Abstract
Incubation of membranes of neuroblastoma x glioma hybrid, NG108-15 cells with GDP beta S followed by immunoblotting of resolved membrane and supernatant fractions with specific anti-peptide antisera showed essentially all of the alpha subunit of Go to be associated with the membrane. Similar experiments with poorly hydrolyzed analogues of GTP caused release of a significant fraction (some 50% within 60 minutes) of Go alpha into the supernatant. This was not mimicked by analogues of ATP. Antisera directed against peptides corresponding to the extreme N and C-termini of GO alpha demonstrated that the released polypeptide was not proteolytically clipped. These experiments show that the alpha subunit of GO need not be invariably bound to the plasma membrane and that guanine nucleotide activation can release the alpha subunit of GO from its site of membrane attachment.
AuthorsH McArdle, I Mullaney, A Magee, C Unson, G Milligan
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 152 Issue 1 Pg. 243-51 (Apr 15 1988) ISSN: 0006-291X [Print] United States
PMID3128978 (Publication Type: Journal Article)
Chemical References
  • Guanine Nucleotides
  • Macromolecular Substances
  • Thionucleotides
  • Guanosine Diphosphate
  • Guanylyl Imidodiphosphate
  • guanosine 5'-O-(2-thiodiphosphate)
  • Guanosine Triphosphate
  • GTP-Binding Proteins
Topics
  • Animals
  • Cell Line
  • Cell Membrane (drug effects, metabolism)
  • GTP-Binding Proteins (metabolism)
  • Glioma
  • Guanine Nucleotides
  • Guanosine Diphosphate (analogs & derivatives, pharmacology)
  • Guanosine Triphosphate (analogs & derivatives)
  • Guanylyl Imidodiphosphate (pharmacology)
  • Hybrid Cells (metabolism)
  • Kinetics
  • Macromolecular Substances
  • Neuroblastoma
  • Thionucleotides (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: